The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

著者: Rudi Micheletti, Isabelle Plaisance, Brian J. Abraham, Alexandre Sarre, Ching-Chia Ting, Michael Alexanian, Daniel Maric, Damien Maison, Mohamed Nemir, Richard A. Young, Blanche Schroen, Arantxa González, Samir Ounzain, Thierry Pedrazzini - Science Translational Medicine 2017 被引用: 337

as a cardiac fibroblast-enriched super-enhancer-associated lncRNA that represents an attractive therapeutic target to reduce the pathological development of cardiac fibrosis in response to MI and prevent adverse remodeling in the damaged heart.